This Viewpoint discusses why the market for biosimilars and the cost savings related to their use have remained smaller than expected in the United States and suggests ways to rectify this situation.
http://ift.tt/2sYaYsF
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
http://bit.ly/2SylJiJ
-
Publication date: Available online 22 March 2017 Source: Medical Journal Armed Forces India Author(s): S.C. Shaw, M.S. Vinod, Amit Devgan ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου